Target Price | €39.25 |
Price | €38.65 |
Potential |
1.55%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Exail Technologies 2026 .
The average Exail Technologies target price is €39.25.
This is
1.55%
register free of charge
€46.00
19.02%
register free of charge
€25.00
35.32%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Exail Technologies to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Exail Technologies stock has an average upside potential 2026 of
1.55%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million € | 373.06 | 451.84 |
15.56% | 21.12% | |
EBITDA Margin | 18.60% | 21.46% |
79.53% | 15.36% |
5 Analysts have issued a sales forecast Exail Technologies 2025 . The average Exail Technologies sales estimate is
This results in the following potential growth metrics:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | -0.21 | 0.64 |
122.58% | 404.76% | |
P/E | 61.48 | |
EV/Sales | 2.31 |
5 Analysts have issued a Exail Technologies forecast for earnings per share. The average Exail Technologies EPS is
This results in the following potential growth metrics and future valuations:
Exail Technologies...
Analyst | Rating | Action | Date |
---|---|---|---|
MIDCAP PARTNERS |
Locked
➜
Locked
|
Locked | Jan 05 2025 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Nov 07 2024 |
Analyst Rating | Date |
---|---|
Locked
MIDCAP PARTNERS:
Locked
➜
Locked
|
Jan 05 2025 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Nov 07 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.